Dividend Research Desk Independent dividend data and analysis

← Back to declarations

TRSBF

3SBio Inc.

Other OTC· Annual dividend· Common Stock · Healthcare / Biotechnology

$2.20 ▲ $0.00(0.00%) as of Jun 17, 2026 17:07 UTC

3SBio Inc. is a China-based investment holding company deeply engaged in the biopharmaceutical sector, encompassing the entire value chain from research and development to manufacturing, marketing, and sales of its innovative products. The company's extensive biopharmaceutical portfolio caters to a wide array of therapeutic needs. This includes treatments for various blood disorders like TPIAO (for chemotherapy-induced or immune thrombocytopenia), EPIAO and SEPO (recombinant erythropoietins for anemia), and SPARIN (a low-molecular-weight heparin for deep vein thrombosis prophylaxis and treatment, as well as for preventing clotting during hemodialysis), alongside Aiyishu for iron-deficiency anemia. Its autoimmune and inflammatory disease offerings feature YISAIPU, a tumor necrosis factor inhibitor effective against rheumatoid arthritis, ankylosing spondylitis, and psoriasis. In the oncology domain, 3SBio provides Cipterbin for HER2-positive metastatic breast cancer (in combination with chemotherapy), Intefen (a recombinant human interferon for lymphatic/hematopoietic malignancies and viral infections), and Inleusin (human interleukin-2 for renal cell carcinoma, melanoma, and thoracic fluid accumulation). Other specialized products address conditions such as male alopecia and alopecia areata (Mandi), acute rejection post-renal transplant (Xenopax), glycemic control in type 2 diabetes (Byetta), and diabetic retinopathy (Qiming Keli). In addition to its pharmaceutical operations, 3SBio diversifies its activities through services encompassing trading, project management, consulting, technology, and agriculture. The company has forged strategic collaboration agreements with a multitude of international partners, including prominent names like AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and the Dana-Farber Cancer Institute. Established in 1993, the company maintains its headquarters in Shenyang, China.

Key Metrics

Current Yield

1.45%

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.0319

The most recent payment scaled to a full year by how often it's paid. A $0.25 quarterly dividend annualizes to $1.00.

Frequency

A Annual

How often the dividend is paid: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

Rank Score

40.7

Our 0-100 house score blending yield, payout safety, growth and momentum. Higher means a stronger profile on those factors in our model — a research score, not advice or a recommendation to buy.

RSI (14)

30

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$2.00 – $4.74

The lowest and highest price over the past year — shows where today's price sits in its recent range.

Payout Ratio

6.77%

The share of GAAP earnings paid out as dividends. Lower leaves more cushion; above 100% means paying out more than the company earns. It shows n/a for BDCs, REITs and funds, which pay out of cash flow / net investment income rather than GAAP earnings, so this ratio doesn't apply.

Years Paying

8

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

S.A.F.E. Dividend Read

S.A.F.E. is our quick durability read on the dividend: Sustainability, Adequacy, Financial strength and Endurance. Each letter flags green (good) or amber (worth a look).
S Sustainable Payout
Payout ratio 7% leaves coverage room.
A Payment Track Record
8 years of dividend payments.
F Fair Valuation
Price-to-book 2.21.
E Entry Signal
Currently oversold — RSI 30. potential entry.

Quote & Key Data

ExchangeOther OTCThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume1,500How many shares changed hands in the latest session — a rough read on trading activity.
Open$2.20The price at the start of the latest trading session.
Day Range$2.20 – $2.20The lowest and highest price during the latest trading session.
Prev Close$2.20The closing price from the previous trading session.
Market Cap$60.21BThe company's total market value: share price times shares outstanding.
Shares Out27.37BThe total number of shares the company has issued.
EPS$3.42Earnings per share — profit divided by shares outstanding. Dividends are paid out of these earnings.
P/E0.6Price-to-earnings ratio: share price divided by earnings per share. A rough gauge of how richly the stock is valued.
Ex-DividendJul 21, 2026Buy before this date to receive the upcoming payment. Buy on or after it and the seller keeps that one.
Pay DateAug 04, 2026The date the dividend is actually paid into shareholders' accounts.

Dividend Growth

3-Yr Growth (CAGR)7.7%The dividend's average annual growth rate over the period, compounded. Steady growth signals a healthy, rising payout.
5-Yr Growth (CAGR)-The dividend's average annual growth rate over the period, compounded. Steady growth signals a healthy, rising payout.
Consecutive Increases0 yrsThe number of years in a row the dividend has increased — a track record of reliability.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.0319 A Regular - Jul 21, 2026 Jul 23, 2026 Aug 04, 2026
$0.0319 A Regular - Jul 21, 2026 Jul 23, 2026 Aug 04, 2026
$0.0318 A Regular - Jul 21, 2025 Jul 23, 2025 Aug 15, 2025
$0.0320 A Regular - Jul 22, 2024 Jul 23, 2024 Aug 05, 2024
$0.0128 A Regular - Jun 27, 2023 Jun 28, 2023 Jul 11, 2023
$0.0255 A Regular - Jun 27, 2022 Jun 28, 2022 Jul 11, 2022
$0.0087 A Regular - Jun 29, 2018 Jul 03, 2018 Jul 30, 2018
View
Theme